Cardinal Health, Inc. operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cardinal Health with three other
drug stores in North America:
McKesson Corporation
(2019
sales of $214.32 billion
of which 78%
was U.S. Pharmaceutical and Specialty Soluti),
AmerisourceBergen Corporation
($179.59 billion
of which 96%
was Pharmaceutical Distribution), and
Walgreens Boots Alliance Inc
($136.87 billion
of which 76%
was Retail Pharmacy USA).
Sales Analysis.
Cardinal Health reported sales of $145.53 billion
for the
fiscal
year ending
June of 2019.
This
represents
an
increase of 6.4%
versus 2018, when the company's sales were $136.81 billion.
Sales at Cardinal Health have increased during each of the previous five years
(and since 2014, sales have increased a total of 60%).
Sales of Pharmaceutical saw an increase
of
7.2% in 2019, from
$121.24 billion to $129.92 billion.